Start for free
Start for free
Innoviva logo

Innoviva

North America, California, United States, Brisbane

Description

Innoviva is committed to building long-lasting value and improving patient care.

Investor Profile

Innoviva has made 9 investments, with 1 in the past 12 months and 89% as lead.

Stage Focus

  • Post Ipo Debt (44%)
  • Series C (22%)
  • Post Ipo Equity (22%)
  • Series Unknown (11%)

Country Focus

  • United States (89%)
  • Switzerland (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Therapeutics
  • Life Science
  • Medical
  • Pharmaceutical
  • 3d Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Innoviva frequently co-invest with?

LB
Luson Bioventures
North America, Indiana, United States, Zionsville
Co-Investments: 1
Taiwania Capital Management Corporation
Taiwania Capital Management Corporation
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
BioCrossroads
BioCrossroads
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Deerfield
Deerfield
North America, New York, United States, New York
Co-Investments: 1
Morningside Venture Investments
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 1
HealthCap
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Thornapple River Capital
Thornapple River Capital
North America, District of Columbia, United States, Washington
Co-Investments: 1
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
North America, Maryland, United States, Bethesda
Co-Investments: 1

What are some of recent deals done by Innoviva?

Armata Pharmaceuticals

Marina Del Rey, California, United States

Armata Pharmaceuticals is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo DebtMar 12, 2025
Amount Raised: $10,000,000
Armata Pharmaceuticals

Marina Del Rey, California, United States

Armata Pharmaceuticals is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo DebtMar 4, 2024
Amount Raised: $35,000,000
Armata Pharmaceuticals

Marina Del Rey, California, United States

Armata Pharmaceuticals is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo DebtJul 11, 2023
Amount Raised: $25,000,000
Armata Pharmaceuticals

Marina Del Rey, California, United States

Armata Pharmaceuticals is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo DebtJan 10, 2023
Amount Raised: $30,000,000
Gate Neurosciences

Carmel, Indiana, United States

Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Series UnknownOct 5, 2022
Amount Raised: $25,000,000
Nanolive

Ecublens, Vaud, Switzerland

Nanolive has developed a disruptive proprietary technology.

3D TechnologyBiotechnology
Series CSep 20, 2022
Amount Raised: $2,200,000
Armata Pharmaceuticals

Marina Del Rey, California, United States

Armata Pharmaceuticals is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo EquityFeb 9, 2022
Amount Raised: $45,000,000
Armata Pharmaceuticals

Marina Del Rey, California, United States

Armata Pharmaceuticals is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo EquityOct 28, 2021
Amount Raised: $7,000,000
InCarda Therapeutics

Newark, California, United States

Incarda Therapeutics offers a novel approach to treat cardiovascular conditions and diseases by the inhalation route.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Series COct 21, 2020
Amount Raised: $30,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator